122 related articles for article (PubMed ID: 7808075)
1. [The effect of the type of factor VIII concentrate on the CD4 lymphocyte count in hemophiliacs with human immunodeficiency virus infection: the results of a meta-analysis].
Montoro Ronsano JB; Oliveras Martín J; Tusell Puigbert JM
Med Clin (Barc); 1994 Nov; 103(18):690-4. PubMed ID: 7808075
[TBL] [Abstract][Full Text] [Related]
2. High versus ultra-high purity factor VIII concentrate therapy: prospective evaluation of immunological and clinical parameters in HIV seronegative and seropositive hemophiliacs.
Varon D; Schulman S; Dardik R; Barzilai A; Bashari D; Martinowitz U
Thromb Haemost; 1994 Sep; 72(3):359-62. PubMed ID: 7855784
[TBL] [Abstract][Full Text] [Related]
3. [Effect of factor VIII concentrates of very high purity on CD4+ cell count in hemophiliacs infected with HIV].
Molina Alejandro R; Lorenzo Herrero JI; Haya Guaita S; Querol Fuentes F; Aznar Lucea JA
Rev Clin Esp; 1996 Jun; 196(6):365-9. PubMed ID: 8767071
[TBL] [Abstract][Full Text] [Related]
4. CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients.
Sabin C; Pasi J; Phillips A; Elford J; Janossy G; Lee C
Thromb Haemost; 1994 Aug; 72(2):214-7. PubMed ID: 7831654
[TBL] [Abstract][Full Text] [Related]
5. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates.
Goldsmith JM; Deutsche J; Tang M; Green D
Thromb Haemost; 1991 Oct; 66(4):415-9. PubMed ID: 1839091
[TBL] [Abstract][Full Text] [Related]
6. Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate.
Mannucci PM; Gringeri A; de Biasi R; Baudo F; Morfini M; Ciavarella N
Thromb Haemost; 1992 Mar; 67(3):310-3. PubMed ID: 1353642
[TBL] [Abstract][Full Text] [Related]
7. Effects of factor VIII concentrates on the immune system of patients with hemophilia.
Mannucci PM
Thromb Haemost; 1995 Jul; 74(1):437-9. PubMed ID: 8578501
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
[TBL] [Abstract][Full Text] [Related]
9. Very-high-purity versus intermediate-purity factor VIII in human immunodeficiency virus-positive hemophiliacs: conclusions of a prospective 3-year study. Monoclate Study Group.
Seremetis SV
Semin Hematol; 1993 Oct; 30(4 Suppl 5):10-3. PubMed ID: 7903480
[No Abstract] [Full Text] [Related]
10. The course of preexistent immune abnormalities in HIV negative haemophiliacs treated for two years with a monoclonal purified factor VIII concentrate.
Smid WM; van der Meer J; Smit JW; Halie MR
Thromb Haemost; 1993 Apr; 69(4):306-10. PubMed ID: 8388579
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D
J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772
[TBL] [Abstract][Full Text] [Related]
12. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
13. In vitro cytopathogenicity of the human immunodeficiency virus (HIV)-1 predicts survival in HIV-infected hemophiliacs independent from CD4 cell count.
Rockstroh JK; Woitas RP; Brackmann HH; Kupfer B; Kaiser R; Schneweis KE; Sudhop T; Spengler U
Eur J Med Res; 1998 May; 3(5):223-30. PubMed ID: 9580568
[TBL] [Abstract][Full Text] [Related]
14. Characterization of GBV-C infection in HIV-1 infected patients.
Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
[TBL] [Abstract][Full Text] [Related]
15. Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates.
de Biasi R; Rocino A; Papa ML; Salerno E; Mastrullo L; De Blasi D
Thromb Haemost; 1994 May; 71(5):544-7. PubMed ID: 8091377
[TBL] [Abstract][Full Text] [Related]
16. [Evolution of CD4 and CD8 lymphocyte subsets in HIV seronegative and seropositive hemophiliacs].
Lorenzo JI; Molina R; Aznar JA
Sangre (Barc); 1993 Feb; 38(1):5-11. PubMed ID: 8470035
[TBL] [Abstract][Full Text] [Related]
17. Purity of factor VIII concentrates and serial CD4 counts. The Transfusion Safety Study Group.
Hilgartner MW; Buckley JD; Operskalski EA; Pike MC; Mosley JW
Lancet; 1993 May; 341(8857):1373-4. PubMed ID: 8098792
[TBL] [Abstract][Full Text] [Related]
18. Immunologic investigation of Chinese hemophiliacs with and without human immunodeficiency virus infection.
Tang DJ; Pang XG
Chin Med J (Engl); 1991 Oct; 104(10):803-7. PubMed ID: 1752140
[TBL] [Abstract][Full Text] [Related]
19. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX
Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827
[TBL] [Abstract][Full Text] [Related]
20. Factor VIII concentrates in HIV-1-positive hemophiliacs--is pure better?
Eichinger S; Pabinger I; Kyrle PA; Köller U; Kier P; Schneider B; Lechner K
Haemostasis; 1992; 22(1):25-31. PubMed ID: 1521824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]